메뉴 건너뛰기




Volumn 29, Issue 1, 2014, Pages 185-192

Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B

Author keywords

Chronic hepatitis B; Entecavir; Lamivudine; Patient adherence; Telbivudine

Indexed keywords

ENTECAVIR; LAMIVUDINE; TELBIVUDINE; VIRUS DNA;

EID: 84897607632     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12416     Document Type: Article
Times cited : (9)

References (17)
  • 1
    • 0036293243 scopus 로고    scopus 로고
    • Global control of hepatitis B virus infection
    • Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2002; 2: 395-403.
    • (2002) Lancet Infect. Dis. , vol.2 , pp. 395-403
    • Kao, J.H.1    Chen, D.S.2
  • 2
    • 59749096640 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592.
    • (2009) Lancet , vol.373 , pp. 582-592
    • Liaw, Y.F.1    Chu, C.M.2
  • 3
    • 0027422748 scopus 로고
    • From hepatitis to hepatoma: lessons from type B viral hepatitis
    • Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262: 369-370.
    • (1993) Science , vol.262 , pp. 369-370
    • Chen, D.S.1
  • 4
    • 0348047588 scopus 로고    scopus 로고
    • Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan
    • Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 2003; 46: 400-407.
    • (2003) Intervirology , vol.46 , pp. 400-407
    • Kao, J.H.1
  • 5
    • 84865376141 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
    • Liaw YF, Kao JH, Piratvisuth T etal. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol. Int. 2012; 6: 531-561.
    • (2012) Hepatol. Int. , vol.6 , pp. 531-561
    • Liaw, Y.F.1    Kao, J.H.2    Piratvisuth, T.3
  • 6
    • 84862664371 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: management of chronic hepatitis B virus infection
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J. Hepatol. 2012; 57: 167-185.
    • (2012) J. Hepatol. , vol.57 , pp. 167-185
  • 7
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: update 2009
    • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662.
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 8
    • 80051498209 scopus 로고    scopus 로고
    • Recent advances in the treatment of chronic hepatitis B
    • Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opin. Pharmacother. 2011; 12: 2025-2040.
    • (2011) Expert Opin. Pharmacother. , vol.12 , pp. 2025-2040
    • Lin, C.L.1    Kao, J.H.2
  • 9
    • 84897612861 scopus 로고    scopus 로고
    • National Health Insurance Administration Ministry of Health and Welfare. Taiwan reimbursement guideline for hepatitis B agents. Cited 27 March 2013. Available from URL. Sections 7.3 and 7.4, Chapter 10.
    • National Health Insurance Administration Ministry of Health and Welfare. Taiwan reimbursement guideline for hepatitis B agents. 2013. Cited 27 March 2013. Available from URL: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=18&menu_id=683&webdata_id=2919&WD_ID=756. Sections 7.3 and 7.4, Chapter 10.
    • (2013)
  • 10
    • 0032499913 scopus 로고    scopus 로고
    • One year trial of lamivudine for chronic hepatitis B
    • Lai CL, Chien RN, Leung Nancy WY etal. One year trial of lamivudine for chronic hepatitis B. N. Engl. J. Med. 1998; 339: 61-68.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 61-68
    • Lai, C.L.1    Chien, R.N.2    Leung Nancy, W.Y.3
  • 11
    • 0034235528 scopus 로고    scopus 로고
    • Effects of extended lamivudine treatment in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
    • Liaw YF, Leung NW, Chang TT etal. Effects of extended lamivudine treatment in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000; 119: 172-180.
    • (2000) Gastroenterology , vol.119 , pp. 172-180
    • Liaw, Y.F.1    Leung, N.W.2    Chang, T.T.3
  • 12
    • 0033592764 scopus 로고    scopus 로고
    • Lamivudine as initial treatment for chronic hepatitis B in the United States
    • Dienstag JL, Schiff ER, Wright TL etal. Lamivudine as initial treatment for chronic hepatitis B in the United States. N. Engl. J. Med. 1999; 341: 1256-1263.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 1256-1263
    • Dienstag, J.L.1    Schiff, E.R.2    Wright, T.L.3
  • 13
    • 58649096155 scopus 로고    scopus 로고
    • 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B
    • Liaw YF, Gane E, Leung N etal. 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 2009; 136: 486-495.
    • (2009) Gastroenterology , vol.136 , pp. 486-495
    • Liaw, Y.F.1    Gane, E.2    Leung, N.3
  • 14
    • 35649020315 scopus 로고    scopus 로고
    • Entecavir treatment for up to 96 weeks in patients with HBeAg positive chronic hepatitis B
    • Gish RG, Lok AS, Chang TT etal. Entecavir treatment for up to 96 weeks in patients with HBeAg positive chronic hepatitis B. Gastroenterology 2007; 133: 1437-1444.
    • (2007) Gastroenterology , vol.133 , pp. 1437-1444
    • Gish, R.G.1    Lok, A.S.2    Chang, T.T.3
  • 15
    • 33644822860 scopus 로고    scopus 로고
    • Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    • Lai CL, Shouval D, Lok AS etal. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N. Engl. J. Med. 2006; 354: 1011-1020.
    • (2006) N. Engl. J. Med. , vol.354 , pp. 1011-1020
    • Lai, C.L.1    Shouval, D.2    Lok, A.S.3
  • 16
    • 78649631236 scopus 로고    scopus 로고
    • Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
    • Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J. Hepatol. 2011; 54: 12-18.
    • (2011) J. Hepatol. , vol.54 , pp. 12-18
    • Chotiyaputta, W.1    Peterson, C.2    Ditah, F.A.3    Goodwin, D.4    Lok, A.S.5
  • 17
    • 84875296320 scopus 로고    scopus 로고
    • Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with lamivudine
    • Kamezaki H, Kanda T, Arai M etal. Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with lamivudine. Int. J. Med. Sci. 2013; 10: 567-574.
    • (2013) Int. J. Med. Sci. , vol.10 , pp. 567-574
    • Kamezaki, H.1    Kanda, T.2    Arai, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.